CD8+ T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+ T Cells <200 Cell/μL: The DART Trial STI Substudy
Figure 1
HIV-specific CD8+ T-cell responses at STI/CT randomization. This figure compares the proportions (%) of participants () inducing (a) HIV-specific IFN-γ or (b) Perforin responses at the time point of STI/CT randomization and proportions of participants inducing (c) HIV-specific IFN-γ or (d) Perforin responses at STI/CT randomization initiated 52 or 76 weeks after ART.
